[
    {
        "utterance": "Jae Sung: Hi everybody. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Hi Emily. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Hi. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Emily, it's nice to see you. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, nice to see you too. Looks like we're going to do this uh facilitate this one together. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, sounds great. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So should we start by going around the room introducing everyone, everyone introducing themselves? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, that sounds good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: You want to start, Emily? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, yeah, that'd be great. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Um so I'm Emily Balskus, I'm in the chemistry department at Harvard University. My lab studies gut bacterial metabolism and enzymes and also develops chemical tools to manipulate and study metabolic activities in microbiomes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: And yeah, do you want to just sort of have uh each person then, you know, introduce the next person. Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Yeah, so maybe um uh Will, you could go next. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Hello, um I'm Will Ludington, I'm at the Carnegie Institution uh and the John Hopkins Biology Department. Um I my lab studies uh gut bacteria in fruit flies and uh think about uh kind of complex uh interactions um in microbial communities. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So you lead us to the next person. You tell us who the next person is. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Redundant instruction",
                    "definition": "Providing explicit instructions or reiterating a process that has already been established or is implicitly understood, which can slow down the discussion or imply a lack of trust in others' ability to follow protocols.",
                    "justification": "The speaker reiterates the instruction for the current speaker to choose the next person, a process that was already proposed and initiated by a previous speaker. The utterance 'So you lead us to the next person. You tell us who the next person is.' directly repeats this instruction."
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Oh, I choose the next one. Sorry. Um uh Elizabeth. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Bess is uh next uh on my screen. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Informal address",
                    "definition": "Using a nickname or overly casual form of address for a new acquaintance in a professional setting, which may be perceived as unprofessional or presumptuous.",
                    "justification": "Will uses the nickname 'Bess' for Elizabeth, whom he is likely meeting for the first time in this professional context, immediately after referring to her as 'Elizabeth' in the previous turn. This shift to an informal address might be perceived as overly familiar. Quote: 'Bess is uh next uh on my screen.'"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Hi folks. Um I'm Elizabeth, I'm from UC Irvine. I'm in the Department of Chemistry. My uh lab studies the chemical reactions happening in the the gut um by facilitated by bacteria. We're really interested um specifically right now we're really interested in and I'm excited about discussion about metal ions, ionciation, um and also um metabolites that are produced by bacteria and consumed uh by bacteria. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Speak to the next person. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Directive Communication",
                    "definition": "The speaker uses imperative language to instruct others, which can be perceived as overly controlling or lacking in collaborative spirit.",
                    "justification": "The speaker uses a direct command, \"Speak to the next person,\" which is a directive rather than an inviting or collaborative prompt, potentially making the interaction feel less collegial."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Oh, I'm sorry. Yes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Um uh Linea. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Linnea Freeman: Hi everyone, I'm Linnea Freeman. I'm at Furman University in the Biology Department and the Neuroscience program. Um my lab looks at sex differences in response to consumption of a high fat, high sugar diet. Um we look at the microbiome changes, but um my my area is more in the brain and we look at neuroinflammation. Uh we focus on astrocytes and microglia. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Narrowing Collaboration Scope",
                    "definition": "The speaker explicitly defines their research focus in a highly specific or limited way, potentially signaling a preference for a narrow range of collaborative topics or partners.",
                    "justification": "Linnea explicitly narrows her primary research focus by stating, 'we look at the microbiome changes, but um my my area is more in the brain and we look at neuroinflammation. Uh we focus on astrocytes and microglia,' which defines a highly specific area of expertise and may limit perceived collaborative opportunities."
                }
            ]
        }
    },
    {
        "utterance": "Linnea Freeman: Um Lisa. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Okay, uh I'm at UBC in Vancouver BC Canada. We study uh neuroinflammation in the context of EAE, so a mouse model of MS. We have a germ free facility here and right now most of our studies are focusing on the effect of an aging microbiota, um dietary interventions that can modulate EAE outcomes and how helmets, so these worms that get into the gut, how they influence EAE outcomes and we're particularly interested um in how things that happen in the gut influence CNS resident uh populations and inflammation. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: So. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: And I will go to Jay, I think is the next one. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Oh. Thanks Lisa. Um hi everybody, I'm Jay Song. I'm up here in uh uh Mayo Clinic in uh Rochester, Minnesota. Um our group is a computational biology and bioinformatics lab. We take a multi-omics approach to study patients with uh with uh autoimmune disease in particular rheumatoid arthritis and vasculitis. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Um so that's kind of more on the clinical and translational side. On the more basic science side, we do uh uh bioinformatics studies um of uh microbial genomes to identify what chemicals, natural products they could be producing and how those uh chemicals could influence uh uh host disease um in the context of autoimmunity. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Excessive Detail",
                    "definition": "The speaker provides an extensive and highly specific description of their research, which, while informative, may overwhelm listeners or make it difficult to quickly identify key areas for potential collaboration.",
                    "justification": "The speaker offers a granular breakdown of their basic science work, including specific methods and research focus, as evidenced by 'On the more basic science side, we do uh uh bioinformatics studies um of uh microbial genomes to identify what chemicals, natural products they could be producing and how those uh chemicals could influence uh uh host disease um in the context of autoimmunity.' This level of specificity might hinder rapid identification of broader collaborative interests during an initial introduction."
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Um okay, so next I'm going to um send this hot potato to Rosa. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Trivializing Contribution",
                    "definition": "Using language that diminishes the importance or value of a participant's upcoming contribution or the act of speaking.",
                    "justification": "The speaker refers to passing the turn to speak as 'send this hot potato to Rosa,' which frames the act of speaking as an undesirable burden rather than a valuable opportunity for contribution."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Thank you for not sending the hot potato earlier because there was vacuuming here in the background. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I appreciate that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Uh this is a good time. So I am Rosa Krahnik Brown or Rosie. I'm an environmental engineer by training. Uh but I have been working with the microbiome for the past 13 years, gut microbiome. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: My my group um uh is interested in um metabolism, how the gut microbiome changes metabolisms and might change um energy extraction by the host, but we also have done a lot of work with autism and the microbiome. And so we look at micro microbe interactions, we look at the environment, of course, and we also look at chemicals, metabolites being produced by these microbes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of Conciseness",
                    "definition": "The speaker provides a lengthy and detailed description of their work or ideas, potentially making it difficult for listeners to quickly grasp key points or identify specific areas for collaboration.",
                    "justification": "The speaker offers an extensive overview of their group's diverse research interests, including metabolism, energy extraction, autism, microbe interactions, environment, and metabolites, which, while informative, could be presented more concisely to facilitate quicker understanding and identification of collaborative opportunities. \"My my group um uh is interested in um metabolism, how the gut microbiome changes metabolisms and might change um energy extraction by the host, but we also have done a lot of work with autism and the microbiome. And so we look at micro microbe interactions, we look at the environment, of course, and we also look at chemicals, metabolites being produced by these microbes.\""
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I need to pass it to someone else, of course, and I was forgetting, but I got it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Uh I know Emily was going to remind me. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Reliance on others for basic tasks",
                    "definition": "The speaker indicates a dependence on another participant for managing basic meeting logistics or remembering simple tasks, rather than taking full personal responsibility. This can subtly undermine perceptions of self-sufficiency.",
                    "justification": "The speaker explicitly states an expectation for another participant to provide a reminder for a basic meeting task: \"Uh I know Emily was going to remind me.\" This suggests a reliance on others for managing the flow of the discussion, rather than taking full personal ownership."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Uh Pamela. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: Hi everyone. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: Hi everyone. Uh my name is Pam Chang. I'm an assistant professor at Cornell. Uh I'm in the Department of Microbiology and Immunology. I'm trained as a chemical biologist and immunologist and my lab um studies the interactions between the gut microbiota and the host immune system um via small molecule metabolites. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: We use mouse models of inflammatory bowel disease and infection. We're interested in the gut brain axis obviously. Um and the other half of my lab works on developing chemical tools to probe the metabolism of the gut microbiota and uh this we're really interested in looking at enzymatic activities carried out by uh bacteria in the gut. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: And then now I'll pick Tom. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Hey, that's good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: I actually went to Cornell for my PhD, so. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Off-topic personal anecdote",
                    "definition": "Sharing a personal detail or story that is not directly relevant to the scientific discussion or the stated goals of the meeting.",
                    "justification": "The speaker shares a personal detail about their educational background ('I actually went to Cornell for my PhD, so.') which, while potentially a rapport-building attempt, does not contribute to the scientific problem domain discussion or the meeting's objective of forming teams for grant proposals."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Um so uh I'm Tom Mansel, I'm from Iowa State University. I'm in chemical engineering. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: And uh our lab focuses on uh our goal is to engineer live biotherapeutics. So uh enabling uh engineered probiotics to secrete small molecules or peptides or proteins that would have a therapeutic effect on the host. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Um and so my goal here is to uh kind of find targets. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: We focus a lot on the chassis uh right now and so uh my goal is to find small molecule metabolites that would be good to have around or get rid of um and uh so I think this discussion will be good for that. I hope. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Tentative Language",
                    "definition": "The use of words or phrases that express uncertainty, hesitation, or a lack of strong conviction, which can subtly undermine the speaker's perceived confidence or commitment.",
                    "justification": "The speaker expresses a positive outlook on the discussion's utility but immediately follows it with 'I hope,' indicating a degree of reservation or tentativeness about the expected outcome. Quote: 'I hope.'"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: And I'll throw it to Mark. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Thanks Tom. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Um so my name is Mark Mimi. I'm an assistant professor at the University of Chicago in the Department of Microbiology and the School of Molecular Engineering. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: And my group is essentially uh a synthetic biology microbiome group. So we're really interested. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: think. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Unidentified Speaker: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Unidentified Speaker: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Can I start with a question based on reading that question? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Or a set of questions. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Um, so when I think about like neurons and brain, I think of like when information is transmitted it's through a synapse is like really uh tightly coupled way to control how the information is transmitted. Um, when I think about like microbial community, I don't I mean like I don't know where that synapse is to even get the bacteria signal there was a secretone part in here. Like how does the bacterial signal get sensed in the first place and are the are the like the abundance of these metabolites enough to like stimulate a signal and are there enough channels, specific channels that could sense one of these metabolites that the bacteria would be uh producing or is it more of an aggregate signal uh from the whole community that's being sensed or uh so be able to point out that it might be like specific molecules that are really important. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Airtime hogging",
                    "definition": "A speaker takes an extended turn, dominating the conversation and limiting opportunities for others to contribute.",
                    "justification": "The speaker delivers a lengthy, continuous monologue, presenting multiple analogies and questions without pausing for others, thereby occupying significant speaking time. \"Um, so when I think about like neurons and brain, I think of like when information is transmitted it's through a synapse is like really uh tightly coupled way to control how the information is transmitted. Um, when I think about like microbial community, I don't I mean like I don't know where that synapse is to even get the bacteria signal there was a secretone part in here. Like how does the bacterial signal get sensed in the first place and are the are the like the abundance of these metabolites enough to like stimulate a signal and are there enough channels, specific channels that could sense one of these metabolites that the bacteria would be uh producing or is it more of an aggregate signal uh from the whole community that's being sensed or uh so be able to point out that it might be like specific molecules that are really important. .\""
                },
                {
                    "code_name": "Unfocused/Rambling contribution",
                    "definition": "A speaker's contribution is lengthy, lacks a clear central point, or presents a disorganized stream of thoughts, making it difficult for others to follow or respond concisely.",
                    "justification": "The speaker presents a long series of interconnected questions and possibilities without a singular, concise focus, which can make it challenging for others to engage effectively. \"Like how does the bacterial signal get sensed in the first place and are the are the like the abundance of these metabolites enough to like stimulate a signal and are there enough channels, specific channels that could sense one of these metabolites that the bacteria would be uh producing or is it more of an aggregate signal uh from the whole community that's being sensed or uh so be able to point out that it might be like specific molecules that are really important. .\""
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Um that is the kind of the point of some of the questions in there. And I'm just curious like to hear people's thoughts about you know, is it one thing that's being sensed or is it kind of a profile things being sensed and how is, you know, if it is one thing like how is is there a directed channel for that thing or is it kind of a distributed network? Um is there a synapse or is there a distributed network that's kind of pulling that signal in? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Does anyone know? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of intellectual engagement",
                    "definition": "The speaker avoids contributing their own thoughts, perspectives, or attempts to grapple with complex ideas or questions, instead deferring the intellectual burden to others.",
                    "justification": "Following a series of complex, open-ended scientific questions, the speaker responds with 'Does anyone know?' (char_offset: 23-39), indicating a reluctance to engage with the substance of the questions or offer their own perspective, instead punting the responsibility for an answer to the group."
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: I'll speak to this. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: Um, so I think that the field is is taking more of a reductionist approach because it's easier to rack your head around, you know, what one metabolite might do or what one family of metabolites might do. But I think that we really should be thinking systemically. I think you're getting at the question of there's as somebody alluded to earlier, thousands of metabolites and they all if they all have activities, what is the summation of all their activities. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Critiquing established methods/norms",
                    "definition": "Expressing a strong opinion that current or established methods or approaches in the field are insufficient or misguided, potentially devaluing the work of others.",
                    "justification": "Pamela critiques the prevailing reductionist approach in the field, stating, 'the field is is taking more of a reductionist approach because it's easier... But I think that we really should be thinking systemically.' This implicitly devalues the current work of many in the field by suggesting a superior alternative."
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: And so I think that's probably more likely that what's going on in vivo, um, although, you know, I think that we're as a field just coming toward that, um, that question. Uh and I think it's a really interesting one for sure. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Chang: But yeah, bottom line, I don't think we know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Closing off inquiry",
                    "definition": "The speaker makes a definitive statement about the current lack of knowledge or an inability to solve a problem, which may discourage further exploration or collaborative problem-solving.",
                    "justification": "The speaker concludes a detailed explanation by stating, \"But yeah, bottom line, I don't think we know.\" (indices 14-59), presenting a definitive lack of knowledge as a final conclusion, potentially hindering further collaborative inquiry into the problem."
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: Probably all of all of the above will. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: I mean, like there's receptors in the epithelial lining that respond to um particular antagonist or agonist. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: Um, microbial produced metabolites could, you know, if you have a leaky gut, they could kind of, you know, the metabolites can find themselves into the circulatory system. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Tentative Language",
                    "definition": "The speaker uses words or phrases that express uncertainty, possibility, or hesitation, rather than making definitive statements, which can undermine confidence in their ideas.",
                    "justification": "The speaker uses phrases like 'could' and 'kind of' to describe a biological mechanism, indicating a tentative explanation rather than a confident assertion: 'microbial produced metabolites could, you know, if you have a leaky gut, they could kind of, you know, the metabolites can find themselves into the circulatory system.'"
                },
                {
                    "code_name": "Excessive Filler Words",
                    "definition": "The speaker frequently uses non-essential words or sounds (e.g., 'um,' 'uh,' 'you know') that interrupt the flow of speech and may detract from the clarity or perceived confidence of their message.",
                    "justification": "The utterance contains multiple instances of 'Um' and 'you know,' which are filler words that can disrupt the flow and potentially diminish the perceived confidence of the speaker: 'Um, microbial produced metabolites could, you know, if you have a leaky gut, they could kind of, you know, the metabolites can find themselves into the circulatory system.'"
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: And who knows what happens after that. Um, you can stimulate the um, kind of the inter endocrine cells to actually make and in turn they make, you know, ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Vague/Incomplete Explanation",
                    "definition": "The speaker provides an explanation that is unclear, lacks sufficient detail, or is left unfinished, making it difficult for listeners to grasp the full concept.",
                    "justification": "The utterance ends abruptly with 'make, you know, .', leaving the explanation incomplete and vague about what the cells actually make. The phrase 'And who knows what happens after that' also contributes to a lack of specific detail."
                },
                {
                    "code_name": "Disfluency",
                    "definition": "The speaker uses filler words or hesitations that interrupt the flow of speech, potentially affecting clarity or perceived confidence.",
                    "justification": "The speaker uses 'Um' twice and trails off with 'you know,' indicating hesitation and a less fluid delivery of information."
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: different types of hormones um that affect other the activities of different tissues. Um, in regards to synapses at the inter nervous system, definitely um could be one mechanism, but apart from that, there's probably various other ways that microbial products could affect the brain. So complex. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Over-complication",
                    "definition": "The speaker emphasizes the extensive complexity or broadness of a problem, potentially hindering the group's ability to narrow down a specific, actionable research focus.",
                    "justification": "The speaker acknowledges one mechanism but then immediately broadens the scope by stating, 'but apart from that, there's probably various other ways that microbial products could affect the brain. So complex.' which highlights complexity without offering a path to focus."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah, along those lines, I don't know if anyone knows about more, but ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Vague/Unclear Communication",
                    "definition": "The speaker's statement is ambiguous, lacks specific details, or is left unfinished, making it difficult for others to fully grasp their intended meaning or contribution.",
                    "justification": "The utterance ends abruptly with 'but', leaving the speaker's thought incomplete and their full point unstated, which makes the communication unclear, as seen in the quote 'I don't know if anyone knows about more, but '."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: I know there have been stories that describe like um rather serotonin or serotonin producing sorry, serotonin producing microbes or GABA producing or consuming microbes uh like evoking this notion that making or depleting neurotransmitters affects uh the gut brain axis. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Has that been shown in different diseases? Like those that microbial activity in the gut to actually affect uh behavior or whatever, you know, neurological phenotype you're looking at. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: So if I understand your question, you're asking whether or not ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Incomplete Thought/Sentence",
                    "definition": "The speaker's utterance is grammatically incomplete or ends abruptly, leaving the thought unfinished and potentially unclear.",
                    "justification": "The utterance \"So if I understand your question, you're asking whether or not .\" is an incomplete sentence, as it ends mid-thought, leaving the listener without the full context of the speaker's clarification attempt."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: there's been a demonstration of microbial communities impacting biological outcome such as uh behavior. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of Specificity/Detail",
                    "definition": "The speaker provides a general statement or answer without offering sufficient specific details, examples, or evidence that would be helpful for the discussion or problem-solving.",
                    "justification": "The speaker makes a general claim about demonstrations existing without providing any specific examples, studies, or mechanisms, which could hinder a deeper scientific discussion. This is evident in the phrase 'there's been a demonstration of microbial communities impacting biological outcome such as uh behavior.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Well, more specifically, um by modulating neurotransmitters. Like I I definitely know that there are papers that have shown that like bug makes this neurotransmitter or it can consume this neurotransmitter. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: And then there's been suggestions that that metabolic activity within the gut has led to, you know, ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: or will impact the nervous system in some way. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of Specificity",
                    "definition": "The speaker uses general or imprecise language, failing to provide concrete details or specific examples, which can hinder clear understanding and scientific rigor.",
                    "justification": "The phrase 'in some way' is vague and lacks the scientific precision expected in a discussion about specific biological mechanisms, potentially hindering a clear understanding of the proposed impact. The utterance states: 'or will impact the nervous system in some way.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Uh but I'm not aware, I'm also not in this field at all, so these studies might be like in the biggest impact journals possible and I'm just completely unaware. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disclaiming Expertise",
                    "definition": "A speaker explicitly states they lack knowledge or are not part of a specific field relevant to the ongoing discussion, potentially limiting their perceived contribution to the topic.",
                    "justification": "The speaker explicitly states a lack of awareness and not being in the field, which could signal a limited ability to contribute to the current topic, as evidenced by 'I'm also not in this field at all, so these studies might be like in the biggest impact journals possible and I'm just completely unaware.'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Uh I just don't know if uh if that exists. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expressing uncertainty about concept",
                    "definition": "The speaker explicitly states a lack of knowledge or certainty regarding the existence or validity of a concept or phenomenon relevant to the discussion. This can hinder collaborative exploration by casting doubt without offering a path forward.",
                    "justification": "The speaker explicitly states, \"I just don't know if uh if that exists,\" indicating personal uncertainty about the existence of the previously discussed concept."
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Yeah, I always hear the serotonin one and it's like when I've like tried to track that down. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: I never find a a really nice I I never find a really nice solid piece of evidence that supports that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Dismissing an idea/claim",
                    "definition": "The speaker explicitly states that an idea or claim lacks sufficient supporting evidence, thereby challenging its validity or merit.",
                    "justification": "The speaker directly dismisses the validity of a previously discussed idea by stating, 'I never find a a really nice I I never find a really nice solid piece of evidence that supports that.'"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: I think that they're like these like metabolomic studies show, hey, it's being produced there. Um, but I haven't found the like, you know, it's like it's also said it's in the um, the smooth muscle uh uh these contractions that a lot of that's just uh very local. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disorganized or rambling speech",
                    "definition": "The speaker's utterance lacks clear structure, includes excessive filler words, or jumps between ideas, making it difficult to follow the main point.",
                    "justification": "The speaker uses numerous filler words and hesitations, such as \"I think that they're like these like metabolomic studies show, hey, it's being produced there. Um, but I haven't found the like, you know, it's like it's also said it's in the um, the smooth muscle uh uh these contractions that a lot of that's just uh very local,\" which makes the statement less concise and harder to process."
                },
                {
                    "code_name": "Vague or imprecise language",
                    "definition": "The speaker uses unclear, ambiguous, or overly general terms, making it difficult for others to fully grasp the intended meaning or specific details.",
                    "justification": "The speaker uses imprecise phrasing like \"I haven't found the like, you know, it's like it's also said it's in the um,\" which lacks specific references or clear articulation of the source or nature of the information."
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Um but the idea that like, yeah, ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: there's a lot of serotonin there, but is it like ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Critical Questioning",
                    "definition": "The speaker raises a question that challenges an existing idea, assumption, or interpretation, which, if persistent, could be perceived as hindering collaborative progress.",
                    "justification": "The speaker acknowledges a fact (\"there's a lot of serotonin there\") but immediately introduces a critical inquiry into its nature or function with the phrase \"but is it like .\""
                },
                {
                    "code_name": "Incomplete Utterance",
                    "definition": "The speaker's utterance ends abruptly or is grammatically incomplete, potentially causing a momentary lack of clarity or requiring the listener to infer the full meaning.",
                    "justification": "The utterance ends with an incomplete phrase, \"but is it like .\", leaving the thought unfinished within this specific turn."
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: being used as a neurotransmitter in that case, it might just be a metabolite. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Downplaying Research Avenue",
                    "definition": "The speaker minimizes the potential significance or validity of a specific research idea, hypothesis, or finding, which could discourage its exploration or consideration by the group.",
                    "justification": "The speaker suggests a less impactful alternative explanation for a phenomenon, potentially diminishing the perceived importance of investigating its role as a neurotransmitter, stating, 'it might just be a metabolite.'"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: So I I totally agree and the serotonin is the one I always ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: like try to track it down, but again, that's not my field, so I would really be curious to know if there is solid evidence for that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Disclaiming Expertise",
                    "definition": "The speaker explicitly states a lack of expertise or knowledge in the current topic of discussion, potentially signaling a limited capacity or willingness to contribute to that specific area.",
                    "justification": "The speaker explicitly states a lack of expertise in the topic being discussed, which might deter potential collaborators looking for specific knowledge or active engagement in that area. Evidence: 'but again, that's not my field'"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: in a better way. I was wondering like, should we be thinking of common or molecules that are common with the nervous system or should we be looking for completely novel molecules that are, you know, bacterially derived that um are influencing the nervous system in some way that we don't currently know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think that's an excellent question because I think there might be molecules that we don't know yet that influence the nervous system. What do you guys think? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And so I will go back to um, I think it was Will's question about production or consumption by specific microbes. There there is evidence on on mice that specific microbes will change the concentrations at least in the in the system in the blood of certain chemicals or neurotransmitters and not not all of them have been recognized as neurotransmitters. Um, so those might be important too. What are your thoughts? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: also kind of depends probably where it's produced, right? If it's produced near the small intestine, probably has a better chance of getting in the serum. Whereas, you know, in the in the colon, you know, it's probably not as much mass transfer there. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: As the chemical engineer, I have to point that out, I guess. That mass transport is a thing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expertise Assertion (Corrective)",
                    "definition": "The speaker explicitly highlights their specific disciplinary expertise to frame their contribution as a necessary correction or reminder, potentially implying a knowledge gap in others.",
                    "justification": "The speaker states, \"As the chemical engineer, I have to point that out, I guess,\" explicitly using their professional identity to justify their statement as a necessary intervention, which can subtly imply others are overlooking a fundamental concept."
                },
                {
                    "code_name": "Implying Obviousness",
                    "definition": "The speaker uses phrasing that suggests a concept is fundamental or self-evident, potentially making others feel less knowledgeable or that their contributions are basic.",
                    "justification": "The statement \"That mass transport is a thing.\" implies that the concept of mass transport is a fundamental and obvious truth, which can make others feel that they are overlooking basic principles."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: So again, I think people a lot of lots of groups brought up biogeography, but um it's definitely something that we need to keep in mind if we're going to harness these this information in some way is, okay, well, this bacterium produces serotonin, well where and how does it get into the serum if so. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: And I don't know, you know, you know, there's direct activation of ENS. This is outside of my purview, right? But how would something get to the the brain by the blood brain barrier, I guess? I have to get in the blood first. Right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Limiting scope of contribution",
                    "definition": "The speaker explicitly states that a topic or area is beyond their expertise or responsibility, potentially narrowing their perceived ability to contribute to broader discussions.",
                    "justification": "Tom explicitly states, \"This is outside of my purview, right?\", indicating a boundary to his expertise on the direct activation of ENS, which might limit his perceived scope of contribution to the overall problem."
                },
                {
                    "code_name": "Expressing uncertainty",
                    "definition": "The speaker uses hesitant language, questions their own statements, or thinks aloud, which might convey a lack of confidence or definitive contribution.",
                    "justification": "Tom uses phrases like \"I don't know,\" \"I guess?\", and \"Right. .\" to express uncertainty about the mechanism of substances reaching the brain, rather than offering a firm hypothesis or question."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Yeah, I'm interested in what sort of studies people or techniques people think about for tracking um for tracking that. Uh so there's in the 70s and 80s before we were concerned about C14 carbon. There's some beautiful studies that show like the tracking of you know, like pharmacokinetics of drugs, um which we leverage a lot um uh in our lab like going back to use those. When you think about the molecules that are produced endogenously, it does get really tricky to me to think about well even if it's getting produced, where does it go from there? Is it going between cells? Like is it crosses the epithelium is it going through a cell, which could matter in terms of we think a lot about oxidation state. If it goes through a cell, this could change like oxidation state as opposed to between cell. And uh this is something we've struggled with in the lab like thinking about how do you actually track those specific molecules that are getting produced where it's more obvious if it's an exogenous source that you're providing like a carbon, we can use C13 labels too, but how do you do that in vivo um and follow where it goes? And I don't I I I love if someone can answer that or like ideas for how people think about that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Excessive self-referencing",
                    "definition": "The speaker frequently refers to their own work, lab, or personal experiences in a way that might monopolize the discussion or frame the problem primarily from their perspective, potentially limiting space for others' contributions.",
                    "justification": "The speaker extensively details their lab's methods and struggles, stating, 'which we leverage a lot um uh in our lab like going back to use those' and 'this is something we've struggled with in the lab.' This lengthy explanation about their specific challenges and approaches could dominate the conversation."
                },
                {
                    "code_name": "Framing problem as uniquely difficult",
                    "definition": "The speaker emphasizes the extreme difficulty or complexity of a problem, often by highlighting their own or their lab's struggles, which might discourage others from offering solutions or make them feel their ideas are inadequate.",
                    "justification": "The speaker explicitly states the problem is 'really tricky to me to think about' and that 'this is something we've struggled with in the lab,' potentially setting a high bar for solutions and discouraging others from contributing."
                }
            ]
        }
    },
    {
        "utterance": "Linnea Freeman: Um, I just wanted to go, sorry, I don't want to interrupt like I can't uh respond to your question, but I was also thinking about what Tom was saying. I think it connects with what you're just saying too and this is so outside of my area, something I want to listen and get information because I have a lot to learn here, but um in terms of crossing the blood brain barrier, that might not be a major like it's certainly a question, but we don't know if there's um small molecules that are traveling that need to get past the blood brain barrier or if for example, we're talking about serotonin activation that's happening in the gut that could then um stimulate the vagus nerve and that would then send a signal to the brain and then, you know, we might not have to get past the blood brain barrier based on who knows if it's a neurotransmitter like dopamine or serotonin produced in the gut. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Self-deprecation",
                    "definition": "The speaker explicitly minimizes their own knowledge or expertise, often expressing a need to learn from others, which can undermine their perceived value to a potential team.",
                    "justification": "Linnea explicitly states the topic is outside her area and she needs to learn, saying, \"this is so outside of my area, something I want to listen and get information because I have a lot to learn here\"."
                },
                {
                    "code_name": "Excessive Apology/Hesitation",
                    "definition": "The speaker uses numerous apologies or hesitant language before making a contribution, which can diminish their perceived confidence or authority.",
                    "justification": "Linnea prefaces her contribution with multiple apologies and disclaimers, stating, \"sorry, I don't want to interrupt like I can't uh respond to your question\"."
                }
            ]
        }
    },
    {
        "utterance": "Linnea Freeman: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah, yeah, one of the techniques that uh or that I I know Michael Fishbach has done a lot of it, but is this idea of using for the defined microbial communities and then doing genetics within the microbes there. So at least there you can envision that if you know microbe A is responsible for the production of this molecule and you can tune that production in a germ free model and then down the line look at that phenotype, you you might depending on whether or not it's also made by the host, you could conceivably track like, okay, the bugs in the gut, it's making this molecule, it's, you know, it's in the serum, it's in the lamina appropriate. Oh, it doesn't make it into the blood brain, so it's not directly acting in those sort of contexts. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: And I think those models are are pretty powerful um although, you know, scaling it to hundreds of molecules and you know, hundreds of different permutations of uh microbial communities makes that a little bit challenging. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Identifies challenges",
                    "definition": "The speaker points out significant difficulties or constraints related to an idea or approach, which may impede its practical application or scalability.",
                    "justification": "The speaker acknowledges the power of the models but immediately follows with a significant challenge: \"scaling it to hundreds of molecules and you know, hundreds of different permutations of uh microbial communities makes that a little bit challenging.\" This explicitly identifies a major hurdle."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Our lab's really interested in the idea of privilege substrates, right? So prebiotics are things that not everybody can eat, right? And ideally there you'd have one that nobody can eat, but your proprietary organism, right? Um, and so uh I really I love the idea of a radio labeled prebiotic such that if you have privilege substrate, it's not going to get converted into dopamine or whatever uh unless that bug uh eats it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lab-centric framing",
                    "definition": "The speaker frames the discussion or introduces an idea primarily through the lens of their own lab's specific interests, existing work, or proprietary approaches, potentially limiting broader collaborative exploration.",
                    "justification": "The speaker immediately introduces the topic by stating, \"Our lab's really interested in the idea of privilege substrates,\" and then elaborates on a specific application involving \"your proprietary organism,\" focusing on their specific research angle rather than a broader, shared problem."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Yeah, so you'd have to have a sufficiently privileged um substrate to do that. And of course you'd have to make it with C13. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Assumes Shared Technical Knowledge",
                    "definition": "The speaker uses language that implies certain technical information or steps are obvious or commonly known, potentially creating a barrier for those who do not share that specific expertise.",
                    "justification": "The phrase 'And of course you'd have to make it with C13' suggests that the necessity of C13 labeling is an obvious technical requirement, which might not be universally understood by all participants, potentially alienating those without this specific knowledge."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balskus: You would need to also know about the actual metabolic pathways in order to to design Right. a substrate, yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Stifling idea generation/momentum",
                    "definition": "The speaker introduces a significant challenge or prerequisite to an ongoing idea discussion without offering a path forward, potentially slowing down or halting the creative flow and enthusiasm.",
                    "justification": "Emily highlights a critical knowledge requirement for the proposed idea, stating, \"You would need to also know about the actual metabolic pathways in order to to design Right. a substrate, yeah.\" This statement, while factual, introduces a hurdle without suggesting how to overcome it, which can impede the momentum of idea development."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: You need to know which bug makes it, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: And engineer that bug to eat the substrate. Yeah, so that could be the kind of that could be the kind of uh high risk, high reward uh thing we're looking for. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly ambitious framing",
                    "definition": "Presenting an idea with an emphasis on its grand potential or inherent difficulty ('high risk') without sufficient grounding in practical feasibility, which may deter collaborators seeking more achievable or less resource-intensive projects.",
                    "justification": "The speaker frames the proposed idea as a 'high risk, high reward' endeavor, which, while potentially innovative, can also signal an overly ambitious scope that might make the project seem less attainable or more challenging than potential collaborators are willing to undertake. The exact quote is: 'high risk, high reward uh thing we're looking for.'"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, there is a um heavy labeled muffin actually that can be used for clinical trials, but it's a substrate that many microbes will eat. And I I just know this because at some point I was also thinking about like, can we label the microbes, not just the substrate, but the microbes because it goes in their DNA. Um but but that's I'm muffin. I know this because when I started working on the microbiome, I asked John Debase who was um who is my collaborator at the Mayo clinic and uh he said, yeah, there's an isotopic muffin, but the problem is that this is not too specific. So it won't give you that specific prebiotic stimulation that you're looking for. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Shutting down an idea",
                    "definition": "Directly dismissing or invalidating a proposed idea or direction, often by highlighting its limitations or impracticality without exploring potential solutions.",
                    "justification": "Rosa acknowledges a related concept (isotopic muffin) but immediately points out a significant limitation that renders it unsuitable for their specific goal, stating, 'the problem is that this is not too specific. So it won't give you that specific prebiotic stimulation that you're looking for.'"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Right. Right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think there's also been some studies that have ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: um leverage the chemical environment as you're traveling through the GI tract to kind of release things at different pH or in different chemical environments, which doesn't have a lot of that is I mean, the precision is not maybe fabulous there, but um could be a way maybe to get some of these small like a C13 labeled molecule to that location because I think that's a big challenge in studying metabolites that if you are like orally dosing some of the metabolites we study, if we orally dose them, they will be immediately absorbed into systemic circulation, but in real life, um that doesn't happen because they're actually um sort of like what Tom's mentioning like part of something that's more complex that doesn't fully get um like perhaps uh hydrolysis of the glucuronide or something. It doesn't happen until you're in the colon and then it releases in the right spot. Um I don't know. So I I don't want to interrupt the conversation, but I've seen that Sarah is very quiet and um we didn't give her a chance to introduce herself because she had to step out. So Sarah, did you want to do a quick introduction and maybe we can hear from you? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Derailing/Shifting Topic",
                    "definition": "The speaker explicitly changes the subject of the discussion away from the current scientific problem-solving or idea generation.",
                    "justification": "The speaker explicitly states, \"I don't want to interrupt the conversation, but I've seen that Sarah is very quiet and um we didn't give her a chance to introduce herself because she had to step out. So Sarah, did you want to do a quick introduction and maybe we can hear from you?\", thereby shifting the focus from the ongoing scientific discussion to a participant's introduction."
                },
                {
                    "code_name": "Calling out quiet participant",
                    "definition": "Directly addressing a participant to highlight their lack of contribution or quietness, potentially putting them on the spot.",
                    "justification": "The speaker explicitly observes and states that \"Sarah is very quiet\" and then directly prompts her for an introduction, which could make the participant feel singled out or pressured."
                }
            ]
        }
    },
    {
        "utterance": "Sarah MacEachern: Yeah, sorry. I apologize. I've had to do two days, you know what it's like, you know, patients come first every day. Um Um yeah, I'm I'm a developmental fellow um who's just offered an assistant professor position at the University of Calgary. So I'm sort of like in the very, very early stages. Um my plan is to use precision medicine approaches to approach neurodevelopmental conditions to try to understand them better, but my PhD work was in the neuroscience of the gut, which has sort of brought me back around to this question of um, you know, sort of microbiome and neurodevelopmental conditions. I have to be honest with you for most other sessions I've felt I've been able to follow and it's probably because I came a little late, but um sort of the level of the scientific discussion has been a bit above me, which is in part why I haven't jumped in yet. So it's been part of what I've really enjoyed about the is that I truly have learned so much and like my day-to-day I think looks very different from a lot of you. So um I don't have anything to add quite yet other than to say like you guys are so smart. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expressing Perceived Inadequacy",
                    "definition": "The speaker explicitly states that they feel the discussion is beyond their current understanding or that they lack the necessary knowledge to contribute meaningfully, which can signal a lack of confidence.",
                    "justification": "Sarah states, \"the level of the scientific discussion has been a bit above me,\" indicating a perceived gap in her understanding relative to the group's discussion."
                },
                {
                    "code_name": "Deferring Contribution",
                    "definition": "The speaker explicitly states that they have nothing to add to the current discussion or have not participated due to perceived inability, thereby signaling a lack of immediate engagement or willingness to contribute.",
                    "justification": "Sarah explicitly says, \"which is in part why I haven't jumped in yet\" and \"I don't have anything to add quite yet,\" indicating a current lack of active contribution."
                },
                {
                    "code_name": "Emphasizing Differences",
                    "definition": "The speaker highlights differences in their background, expertise, or daily work compared to other participants, which can inadvertently create a sense of separation or 'outsider' status.",
                    "justification": "Sarah notes, \"my day-to-day I think looks very different from a lot of you,\" which emphasizes a distinction between her work and that of the other participants."
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: You're so smart. Okay. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Patronizing Compliment",
                    "definition": "Offering praise that, in context, can be perceived as condescending or dismissive, especially when it follows an expression of vulnerability or difficulty, failing to genuinely address the speaker's concerns.",
                    "justification": "Jae Sung's 'You're so smart' immediately follows Sarah's admission of feeling out of her depth and having nothing to add. This compliment, while seemingly positive, can be perceived as patronizing as it doesn't address her actual concern about participation and instead offers a generic, potentially dismissive, affirmation. The quote 'You're so smart' provides evidence."
                },
                {
                    "code_name": "Dismissive Acknowledgment",
                    "definition": "Acknowledging a speaker's contribution or concern in a way that minimizes its importance or shuts down further discussion, rather than engaging with it constructively.",
                    "justification": "The utterance ends with 'Okay.', which, in response to Sarah's vulnerable statement about feeling out of her depth, acts as a dismissive acknowledgment, failing to address her expressed difficulty or invite her further into the conversation. The quote 'Okay.' exemplifies this."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I I I just want to make sure you you had an opportunity. So let us know raise your hand. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Controlling Turn-Taking",
                    "definition": "The speaker dictates or imposes a specific method for participants to signal their desire to speak, potentially hindering spontaneous contributions and natural conversational flow.",
                    "justification": "The speaker explicitly instructs participants on how to indicate their wish to speak, stating, 'So let us know raise your hand.' This directive can make the discussion feel overly formal and stifle organic interaction."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Maybe maybe maybe you can think about how do we measure these in for ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Incomplete Thought",
                    "definition": "The speaker's utterance ends abruptly, leaving a sentence or idea unfinished and requiring additional context or clarification to be fully understood.",
                    "justification": "The utterance 'Maybe maybe maybe you can think about how do we measure these in for .' is grammatically incomplete, ending mid-sentence with 'in for', which makes the thought unclear without the subsequent utterance."
                },
                {
                    "code_name": "Hesitant Suggestion",
                    "definition": "The speaker presents an idea or suggestion with noticeable hesitation or uncertainty, potentially diminishing its impact or the speaker's perceived confidence.",
                    "justification": "The triple repetition of 'Maybe' at the start of the suggestion ('Maybe maybe maybe you can think about') conveys a strong sense of hesitation or lack of conviction."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: precision medicine actually in humans. So that's one I'm interested in. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Sarah MacEachern: I know that's something I've been wondering about for a while, totally. And worst case I'll just be your guys's hype girl, be like, you know, what's up? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Self-deprecating contribution",
                    "definition": "The speaker explicitly downplays their own potential scientific or intellectual contribution to a potential project, positioning themselves in a less substantive or supportive role.",
                    "justification": "Sarah states, \"And worst case I'll just be your guys's hype girl,\" which explicitly positions her as a supportive, non-technical role rather than an equal scientific contributor, potentially undermining her own value to the team."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balakus:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: I think, you know, just to kind of steer the conversation in your direction that, uh, if you, uh, you know, we talk about precision medicine and we thought, okay, well, let's sequence everybody's microbiome and we'll we'll administer a drug based on your microbiome, but, um, what about, you know, the same, not that anybody would have exactly the same microbial composition, right? That would be, uh, very unusual. But like, you know, the same a similar composition might give you totally different phenotypes in a in two hosts, right? And so like maybe there are metabolomic ways of, uh, of doing precision medicine that that where key metabolites are measured and you can say, okay, well, you know, if this person has a lot of build up of X, you know, it means that means something about metabolism of whatever drug of the of the line. Is is that a thing? Um, or are people really focusing on genetics and micro, you know, ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: the first and second genome, let's say as the, um, as the the focus for precision medicine. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: I mean, I think more and more people are looking at the metabolome as as an output for a variety of diseases, either in a targeted way, looking at, you know, other amino acids or short chain fatty acids or bile acids, or there's some efforts to do untargeted metabolomics, but obviously that's really difficult and at least in clinical trials that are starting to get more and more integrated because there's been this appreciation that yeah, knowing the catalog of the bugs that's there is maybe a little bit predictive of what's going on, but it definitely doesn't, uh, show the full picture. So looking at the transcriptional profile or the metabolomic profile, that might be a little bit more informative for, uh, for what's occurring. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Downplaying alternative approach",
                    "definition": "The speaker minimizes the significance or completeness of a scientific approach or methodology that differs from their own, potentially undermining other participants' expertise.",
                    "justification": "Mark Mimee states that 'knowing the catalog of the bugs that's there is maybe a little bit predictive of what's going on, but it definitely doesn't, uh, show the full picture,' thereby downplaying the utility of microbiome research in comparison to metabolomic or transcriptional profiling."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: How do we determine what what are the ones we need to look at? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Is it metabol, right? Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Vague/Ambiguous Communication",
                    "definition": "Communication that lacks clarity, precision, or specificity, making it difficult for others to fully understand the intended message or leading to potential misinterpretations.",
                    "justification": "The speaker uses a fragmented term 'metabol' instead of a complete scientific term, and the utterance ends with a somewhat unclear 'right? Yeah.', which could lead to ambiguity about the exact point being made or confirmed. Quote: 'Is it metabol, right? Yeah.'"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, just like Emily said, we need to know what you're looking for, right? You need to know the pathways. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Prescriptive Statement",
                    "definition": "The speaker dictates a specific piece of knowledge or action as a prerequisite or solution, rather than collaboratively exploring options. This can stifle open discussion.",
                    "justification": "The statement \"You need to know the pathways\" is prescriptive, dictating a specific requirement for knowledge rather than engaging in a collaborative discussion about how to proceed or what to look at."
                },
                {
                    "code_name": "Shifting Responsibility",
                    "definition": "The speaker places the burden of clarity, definition, or foundational knowledge entirely on other participants, rather than framing it as a shared group challenge. This can create an adversarial dynamic.",
                    "justification": "By stating \"we need to know what you're looking for\" and \"You need to know the pathways,\" the speaker shifts the responsibility for defining the problem and possessing foundational knowledge onto the other participants."
                }
            ]
        }
    },
    {
        "utterance": "Emily Balakus: Yeah, and just to because I think there's kind of two themes in the prompts of kind of discovery and then there's a a mention of the specific kind of neuroendocrine signals like uh neurotransmitters. And so there's kind of we're at different levels of our understanding I think when we sort of consider those two, you know, prompts. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Identifying conceptual misalignment",
                    "definition": "The speaker explicitly points out a divergence or lack of shared understanding regarding core concepts, problem definitions, or prompt interpretations within the group.",
                    "justification": "The speaker states that the group is 'at different levels of our understanding' regarding the two themes in the prompts, indicating a potential lack of a unified conceptual framework for discussion. Quote: \"we're at different levels of our understanding I think when we sort of consider those two, you know, prompts.\""
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Tom, did we answer your question about pharmaceutical drugs? You mentioned something about pharmaceutical drugs, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Oh, well, I just thinking of precision medicine in terms of, uh, you know, dosing or administering particular drugs to a patient. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Um, can you use the gut metabolome or the serum metabolome to, uh, make decisions about that, about, you know, uh, liver activity or, uh, you know, uh, those kinds of things. But, you know, in in microbial context, I'm not sure that okay, we used your microbiome and we determined that we should give you this drug. I don't think that that's just using the microbiome is a good probably going to be a good predictor. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Prematurely Dismisses Idea",
                    "definition": "The speaker quickly rejects or casts strong doubt on a concept or approach, often without sufficient exploration or consideration of alternatives, potentially stifling collaborative brainstorming.",
                    "justification": "Tom poses a question about using metabolome/microbiome for decisions but then immediately dismisses the idea of using the microbiome as a good predictor for drug decisions, stating, \"I don't think that that's just using the microbiome is a good probably going to be a good predictor.\""
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Another question, um, kind of I think related to all of this is, um, if there's some signal that's being transmitted from the gut to the brain, like how close is it to saturation? So like if could we do an experiment where we added more of the, you know, the ligand and then we see would it go would whatever we're measuring would it go up or are we basically like a normal person is always saturated and it's only these cases where we get some kind of depletion, something's wrong where where we see an effect. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: In which case, you know, there's certain kind of studies that that we're limited to, you know, what we can do. So if and we'd have to do deletion experiments and then the deletion experiments seem like they're really hard. Mark was talking about like using fage, um, but then again that's like you have to design a fage for each species. Um, is it like could we, you know, do like kind of combinatorial like chemical libraries, uh, like just go straight to the metabolites or is there like I think Jay talked about like is there a list, a prioritized list of metabolites, um, that we could kind of come up with, um, that we could kind of add in more and see, you know, give each one to see if it changes our output or is it like or is there a way chemically to deplete certain things like you design an enzyme to break, um, whatever metabolite you're looking for, I don't know. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Raises practical barriers",
                    "definition": "The speaker identifies significant practical difficulties, limitations, or complexities that make a proposed idea or approach seem unfeasible or overly challenging, potentially discouraging further exploration.",
                    "justification": "The speaker highlights the inherent difficulty of certain studies and deletion experiments ('there's certain kind of studies that that we're limited to, you know, what we can do. So if and we'd have to do deletion experiments and then the deletion experiments seem like they're really hard') and immediately points out a major practical hurdle for using fage, stating, 'Mark was talking about like using fage, um, but then again that's like you have to design a fage for each species.'"
                },
                {
                    "code_name": "Expresses uncertainty",
                    "definition": "The speaker explicitly states a lack of knowledge or certainty regarding a topic, question, or proposed solution.",
                    "justification": "The speaker concludes a series of exploratory questions with an explicit admission of uncertainty, stating, 'I don't know.'"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: pharmacodynamics basically versus, you know, most people talk about pharmacokinetics, right? But pharmacodynamics is just important. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Subtly challenging common focus",
                    "definition": "The speaker highlights a prevalent area of discussion or research, while implicitly suggesting that another, less discussed aspect is equally or more critical.",
                    "justification": "The speaker notes that 'most people talk about pharmacokinetics, right?' and then immediately asserts that 'pharmacodynamics is just important,' subtly implying that the common focus might be overlooking a crucial element.",
                    "quote": "most people talk about pharmacokinetics, right? But pharmacodynamics is just important."
                },
                {
                    "code_name": "Asserting importance without justification",
                    "definition": "The speaker declares a concept or idea to be significant without providing immediate reasoning, evidence, or explicit connection to the ongoing discussion.",
                    "justification": "The speaker states 'But pharmacodynamics is just important' as a definitive statement, without elaborating on why it is important or how it relates to the preceding detailed questions from other participants.",
                    "quote": "pharmacodynamics is just important."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Yeah, I think I think that that's a this looks like a job for live, uh, you know, live bacteria in there that would be secreting enzymes that I mean, yeah, you can probably deliver enzymes with certain, uh, uh, world delivery mechanisms, but, you know, supplying different levels of, for example, serotonin or whatever, uh, you can just that this sounds well to me, every, you know, I have a hammer, right? Uh, and this looks like something I can hit with it, uh, you know, in terms of synthetic biology, you can design different promoters that would make different amounts of serotonin and then I I I really like that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Premature solution proposal",
                    "definition": "The speaker quickly offers a specific solution early in the discussion, potentially before the problem has been fully explored or understood by the group.",
                    "justification": "The speaker immediately suggests a specific approach by saying, \"this looks like a job for live, uh, you know, live bacteria in there that would be secreting enzymes,\" without first engaging in broader problem definition or exploration."
                },
                {
                    "code_name": "Narrowing focus to own expertise",
                    "definition": "The speaker frames the problem primarily through the lens of their specific domain of expertise, potentially limiting the consideration of diverse perspectives or solutions.",
                    "justification": "The speaker explicitly states, \"I have a hammer, right? Uh, and this looks like something I can hit with it, uh, you know, in terms of synthetic biology,\" indicating a tendency to apply their specific domain knowledge as the primary solution framework."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Uh, that that point of view though in terms of saturation because yeah, you can make all the serotonin you want, but if it's already saturated, who cares, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Dismissive",
                    "definition": "The speaker expresses a lack of interest or importance in an idea, or rejects it without constructive engagement, potentially discouraging further discussion.",
                    "justification": "The speaker uses a rhetorical question to dismiss the relevance of an idea, stating 'who cares, right?' if a certain condition (saturation) is met, which can discourage further discussion."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Um, yeah, I really like that, uh, um, approach. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: But yeah, that's that's certainly something that I can look into it. And and you know, there there are, um, very bugs out there that are engineered, for example, to screen enzymes to get rid of build up of phenyline, um, and uh, oxalic acid and hyper ammonia, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expertise Dominance",
                    "definition": "The speaker emphasizes their specialized knowledge or experience, often by providing detailed examples from their field, which can inadvertently dominate the discussion and limit space for other perspectives.",
                    "justification": "The speaker acknowledges a point but then immediately elaborates on specific examples of engineered bugs and their functions, showcasing their detailed knowledge in a way that shifts the focus to their expertise. \"And and you know, there there are, um, very bugs out there that are engineered, for example, to screen enzymes to get rid of build up of phenyline, um, and uh, oxalic acid and hyper ammonia, right? .\""
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Uh in the gut, um, those are in clinical trials right now. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Um, not mine, but uh. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Pamela Changi: Another crude way to get back on into the linear range is to treat with antibiotics. And then if you can eliminate, if you know which bacteria are making the metabolites of interest, you can then knock down the level and then and then rescue. Um, and then and then you wouldn't be saturated anymore. But it's quite possible a lot of the metabolites are saturating at the steady state. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Highlighting inherent difficulty",
                    "definition": "The speaker points out a fundamental or systemic obstacle, limitation, or inherent difficulty within the problem domain, which may make solutions seem less feasible or the problem harder to address.",
                    "justification": "Pamela states, \"But it's quite possible a lot of the metabolites are saturating at the steady state.\" This highlights an inherent difficulty in the system being discussed, suggesting that the problem of saturation might be a persistent challenge regardless of the specific intervention."
                },
                {
                    "code_name": "Self-undermining suggestion",
                    "definition": "The speaker proposes an idea or solution but immediately follows it with a statement that diminishes its feasibility, utility, or likelihood of success, thereby weakening their own contribution.",
                    "justification": "Pamela suggests \"Another crude way to get back on into the linear range is to treat with antibiotics,\" but then immediately qualifies it with a significant potential problem: \"But it's quite possible a lot of the metabolites are saturating at the steady state.\" This caveat directly undermines the practicality of her own proposed method."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I I want to steer the pot a little bit and say that, um, I've heard great comments about, um, neurotransmitters, metabolites and I can say maybe small molecules, but no one had said anything about metal ions. And I see that that is a title in our topic. So anyone has something you would like to share about metal ions? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Redirecting Discussion Flow",
                    "definition": "The speaker explicitly takes control of the conversation's direction, often by introducing a new topic or shifting focus away from the current discussion.",
                    "justification": "The speaker explicitly states their intention to change the topic, saying, \"So I I want to steer the pot a little bit... And I see that that is a title in our topic.\""
                },
                {
                    "code_name": "Highlighting Omission",
                    "definition": "The speaker points out a topic or aspect that has been missed or not discussed by the group, potentially implying a deficiency in the current conversation.",
                    "justification": "The speaker explicitly notes a gap in the discussion by stating, \"...but no one had said anything about metal ions.\""
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: I love metal ions. So, um, I I'm excited to see that in the last couple of years that there's been um an increasing appreciation in the literature for the importance of measuring redox potential of the microbiome. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: and also the difficulty of measuring this. Um, that is, uh, when, um, there have been studies about redox potential in microbial communities for decades, but there's also a huge body of literature that talks about how hard it is to have reproducibility across experiments. So like if you have a redox potential measured in one study, it's probably reasonable to be consistent within a study, but across studies, the numbers that they change by like or like orders of magnitude of 10 or 100, um, that are, um, that are dramatic. And one of the things that, um, I'm interested in if anyone has comments on this is, um, how can we measure metal ions better in the gut and in real time? And this has been a huge challenge in the chemical biology field. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Highlighting complexity/difficulty",
                    "definition": "The speaker repeatedly emphasizes the intricate, challenging, or difficult nature of a problem or task, potentially making it seem insurmountable or discouraging others from engaging.",
                    "justification": "The speaker explicitly states 'the difficulty of measuring this', describes 'how hard it is to have reproducibility across experiments', and concludes by noting it 'has been a huge challenge in the chemical biology field'."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Um, this is really hard with iron, um, in in the like in a complex system, um, where we are is like synchotron is the only way you can actually measure, um, iron speciation as far as I know right now, um, in, um, biological systems. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Emphasizing technical hurdles",
                    "definition": "The speaker focuses on the significant technical challenges or limitations of a proposed approach or problem, potentially discouraging collaborative problem-solving or making the task seem unfeasible.",
                    "justification": "The speaker explicitly states the process is 'really hard' and identifies a highly specialized and potentially inaccessible method ('synchotron is the only way') as the sole known solution, highlighting significant technical barriers. Quote: 'this is really hard with iron' and 'synchotron is the only way you can actually measure'."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: So it's like doable, but it's not does anybody know how to use one? I don't. I know you can like get time on these, but um it's really complicated. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expressing Personal Limitation",
                    "definition": "The speaker explicitly states their own lack of knowledge, skill, or ability regarding a proposed method or tool, which can inadvertently discourage others or signal a lack of confidence in pursuing the idea.",
                    "justification": "Elizabeth explicitly states her personal lack of expertise with the synchotron by saying, \"I don't.\""
                },
                {
                    "code_name": "Highlighting Difficulty Without Solution",
                    "definition": "The speaker emphasizes the complexity or difficulty of a task, method, or problem without offering potential solutions, strategies, or a clear path forward, which can deter collaborative effort.",
                    "justification": "Elizabeth highlights the significant challenge of using a synchotron by stating, \"it's really complicated,\" without proposing how to overcome this complexity."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: And so it would be um interesting to think about ways to be able to better measure speciation in vivo. You can do this in some ways with like sealgans, there are probes that work to measure iron three specifically in sealgans in a live context. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess:  ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Elizabeth, um, ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: do you do you know if um micro microbes uh they secrete like siderophores? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae-Sung Moon: in the in the gut in in the gut environment. I know it happens in soil, but like is there a lot of insoluble iron in the gut that microbes can kind of sense and be like, hey, I'm going to send out these siderophores to mine for us. Does that happen? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Yeah, yes. So what the the thought is is we make an assumption in the field that iron is mostly in the reduced state in the gut because the gut is a reducing environment, but um, but there are times when there is more iron three oxidized form, which can happen through inflammation, um, through you know, production of Ross or nitric oxide species. Um, but yeah, bacteria do secrete siderophores in uh the the microbiome. The human also secretes enzymes to capture uh iron three, reduce it to iron two so that it can be brought inside of cells. But I think we have a poor understanding of the dynamics of that. Um, how much of the iron is three versus two. I also fascinated that we have that the body it's the iron is so valuable as you know, as we know, for so many processes that there's no way for the body to um, the body doesn't regulate iron levels except for excretion through stool. That's its only way to get like rid of it. Um, and it's um, but we don't understand really the dynamics of what's happening there and um what the the yeah, oxidation states are and how this changes with dysbiosis of a microbiome. Um, what does this mean at like an uh metal a metal level specifically iron is what what I'm you know wonder about. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Long monologue",
                    "definition": "A speaker delivers an extended, uninterrupted speech that occupies a significant portion of the conversation, potentially limiting opportunities for others to contribute.",
                    "justification": "The speaker provides a very detailed and lengthy explanation in response to a question, taking up a substantial amount of airtime without explicit pauses or invitations for others to interject. This is evident in the extended explanation starting with 'So what the the thought is is we make an assumption in the field that iron is mostly in the reduced state in the gut because the gut is a reducing environment, but um, but there are times when there is more iron three oxidized form, which can happen through inflammation, um, through you know, production of Ross or nitric oxide species. Um, but yeah, bacteria do secrete siderophores in uh the the microbiome. The human also secretes enzymes to capture uh iron three, reduce it to iron two so that it can be brought inside of cells. But I think we have a poor understanding of the dynamics of that. Um, how much of the iron is three versus two. I also fascinated that we have that the body it's the iron is so valuable as you know, as we know, for so many processes that there's no way for the body to um, the body doesn't regulate iron levels except for excretion through stool. That's its only way to get like rid of it. Um, and it's um, but we don't understand really the dynamics of what's happening there and um what the the yeah, oxidation states are and how this changes with dysbiosis of a microbiome. Um, what does this mean at like an uh metal a metal level specifically iron is what what I'm you know wonder about. .'"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And what does it mean for gut brain communication too, right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Prematurely broadening scope",
                    "definition": "The speaker introduces a new, broader topic or implication before fully exploring or engaging with the details of the current discussion point, potentially diverting attention from specific expertise.",
                    "justification": "The speaker immediately shifts the discussion from the detailed explanation of iron dynamics in the gut to a broader implication concerning 'gut brain communication,' without first engaging with the specifics just presented. Quote: 'And what does it mean for gut brain communication too, right.'"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Right. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Any other thoughts? That was amazing. Thank you, Elizabeth. That was fascinating. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Baleikus: Maybe to give people just a little bit of a time uh update. I think we have about 20 minutes left. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So I think in five minutes we should start summarizing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Rushing Discussion",
                    "definition": "The speaker attempts to accelerate the discussion towards a conclusion, potentially limiting the time for thorough exploration of ideas and stifling emergent thoughts.",
                    "justification": "The speaker explicitly suggests moving to summarization in a short timeframe, stating, \"So I think in five minutes we should start summarizing.\" This action can prematurely cut off further collaborative idea generation."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Just on the topic of metal ions here. Um, I uh one thing I wrote down was and this is probably pretty wacky. Um, but uh can you spoof like so some so I'm thinking of of PCR, right? When you do PCR, most of us probably at least have done PCR at least I think. Uh, you use magnesium, but if you spoof in manganese, you screw up the polymerase and it gets error prone, right? Can if you substitute or or or put in like some cobalt or something, uh, you know, in the in the microbiome, I wonder how that would change I'm not saying we don't those people with heavy metals, right? But like uh, you know, something a related uh cat ion, right? It's not like iron probably doesn't have a good um ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Self-deprecation",
                    "definition": "The speaker explicitly devalues their own idea or contribution, potentially undermining its perceived worth or their own credibility.",
                    "justification": "Tom prefaces his idea by calling it 'wacky,' which can diminish its perceived value and his confidence in presenting it. Verbatim quote: 'this is probably pretty wacky.'"
                },
                {
                    "code_name": "Vagueness/Lack of clarity",
                    "definition": "The speaker's communication is unclear, rambling, or lacks a precise point, making it difficult for others to understand or engage with the idea effectively.",
                    "justification": "The speaker's concluding remarks are convoluted and difficult to follow, hindering clear communication of their point. Verbatim quote: 'I'm not saying we don't those people with heavy metals, right? But like uh, you know, something a related uh cat ion, right? It's not like iron probably doesn't have a good um .'"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Gallium. Gallium. Okay, yeah. I don't know about that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expressing personal uncertainty",
                    "definition": "The speaker explicitly states a lack of personal knowledge or certainty regarding a proposed idea, which can implicitly discourage further discussion or exploration of that idea.",
                    "justification": "Elizabeth states, \"I don't know about that,\" explicitly indicating her personal uncertainty about the idea of gallium's application, which could hinder its immediate collaborative exploration."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: That sounds interesting. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: There's actually a drug. The um there's a drug that's called Gamite, I think. It's gallium nitrate um that is used it um uh is a really good mimic like um chemically for iron. It doesn't have the same redox properties, but it kind of um it binds to enzymes in a similar way that iron does. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Like just what what would be the if you replaced an animal's iron intake with a little bit of gallium, what would that effect be on the microbiome? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Baleikus: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: I mean that would probably huge, right? I mean one of the things we work with is E coli Nissle and E coli Nissle is a form of E coli that is probiotic. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: You know, just like anything you would go to the store and buy as probiotic. So probably not super good for you, but you can still tolerate it. Uh, but anyway, it's E coli and it it it makes a lot of one of its differences between that and like lab E coli or pathogenic E coli is iron transport. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly casual language",
                    "definition": "Using language that is too informal or colloquial for a professional scientific discussion, potentially signaling a lack of seriousness or precision.",
                    "justification": "The speaker uses the informal phrase \"probably not super good for you, but you can still tolerate it\" when discussing a scientific topic, which may be perceived as unprofessional or lacking rigor in a collaborative setting."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Uh and siderophore production. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: So like it transports iron like crazy and in doing so takes over the E coli and Shigella on Shiga toxin producing E coli niche. So, um like that that to me seems like a great like interface, right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Presumptive Agreement",
                    "definition": "The speaker uses a tag question or phrasing that assumes the listener will agree with their statement, potentially discouraging alternative viewpoints or deeper discussion.",
                    "justification": "The speaker concludes their statement with 'right?', which implicitly seeks confirmation of their idea rather than openly inviting diverse perspectives or critical engagement, potentially limiting collaborative exploration. The verbatim quote is: 'right?'"
                }
            ]
        }
    },
    {
        "utterance": "Emily Baleikus: And so cool. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Baleikus: One other quick metal fact that I found really interesting is that if you like look into the defects that germ free mice have, um, impaired metal homeostasis is actually a really big thing. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Emily Baleikus: Like they have problems with metal uptake. Uh, and I'm not really sure that we understand why. So I think there's a lot of a lot of interesting metal chemistry potentially going on in the microbiome that we just we don't understand. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think I would summarize the the the the metal scenario as uh what Elizabeth mentioned for um redox uh conditions or electron acceptors. I think that's um a way to think about it and as um uh enzyme cofactors. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: So there's two different categories that these metals are really needed for those two things. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: So what's needed according to Elizabeth, I guess in this field or this sub sub sub area is um uh really good sensors or or for in vivo metal content, not only by element or ion type, but by species of that element, right? So Elizabeth if you had an iron three versus iron two sensor that would would give you a read out in vivo in in feces that would be pretty cool. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Informal/Trivializing Language",
                    "definition": "The use of overly casual or informal language when discussing scientific concepts or needs, which can inadvertently diminish the perceived importance, complexity, or seriousness of the topic in a professional setting.",
                    "justification": "The speaker uses the informal phrase 'pretty cool' to describe a significant scientific advancement (an in vivo iron sensor). While potentially enthusiastic, this casual language may inadvertently diminish the perceived seriousness or importance of the scientific challenge in a professional context, which could be detrimental to team formation or grant success. \"So Elizabeth if you had an iron three versus iron two sensor that would would give you a read out in vivo in in feces that would be **pretty cool**.\""
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: I would be so happy. Yes. Yes, that would um yeah, I think that is I think many people would be so happy. But specifically for iron three and not activated by iron two or any other trivalent. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Over-specification of requirements",
                    "definition": "Providing excessively detailed or restrictive technical requirements for an idea or solution, which may inadvertently increase perceived difficulty or narrow the scope for collaboration.",
                    "justification": "The speaker immediately adds a highly specific technical constraint to a proposed idea, stating, \"But specifically for iron three and not activated by iron two or any other trivalent.\" This level of detail could make the problem seem overly complex or niche for potential collaborators."
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Sure. Uh I I'm trying to put them onto the sorry, I'm just trying to find the right button here. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Technical Difficulty/Distraction",
                    "definition": "The speaker is explicitly engaged in resolving a technical issue or is otherwise distracted, diverting their attention from the primary discussion.",
                    "justification": "The speaker explicitly states they are dealing with a technical issue, saying, \"I'm just trying to find the right button here.\" This indicates a momentary distraction from the scientific discussion."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Just trying to get my notes from here onto um our actual slide here. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Logistical Interruption",
                    "definition": "The speaker interjects with a comment about a personal administrative or technical task, temporarily diverting the conversation from the scientific discussion.",
                    "justification": "The speaker explicitly states they are \"Just trying to get my notes from here onto um our actual slide here,\" indicating a focus on a personal organizational task rather than direct engagement with the ongoing scientific dialogue."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: So so far what I've got is I heard a lot about sort of known knowns or known unknowns versus unknown unknowns. Let's get that together. So whether or not um there's benefit to looking at targeted versus untargeted metabolomics and if you do have a candidate that you're interested in like really following the mechanism of how this metabolite is getting across the blood brain barrier acting locally on a Vegas nerve, um what it might be doing to the gut, which cell types might be interacting with or the opposite approach of just like this is everything that exists and they happen to be different. The metabolite black box is different in a disease state versus a healthy state. And so that means that there is something going on and then what are the next steps for characterizing and understanding what those differences mean. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: getting the rest of this over here. Uh, there was a good conversation about tracking these metabolites and so different approaches to doing that. Um, C13 labeling, like I think it was Elizabeth was saying it's really easy if you know what candidate you're looking at, you can make a C13 label and then you can follow that in the gut, in the tissues all the way up to the brain if that's what you're interested in. But if you don't want to provide an exogenous signal, how do you get how do you have that same tracking capability? And so there was this discussion of genetically tractable microbes, either under or over expressing something or using these privileged substrates and whether or not we can I think the the idea was labeling the substrate and then following that through the bug and then through the host, is that right? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Yeah. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Yeah, I think the idea was following the metabolites produced by the by the either the micro or the host that will be labeled because they come from that substrate. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Yes. Okay. Um, and then even targeted ways of getting that substrate to a certain area. So I guess the idea would be like if you know that a microbe lives in the small versus the large intestine, depending on pH or osmolality or some other physical signal, that substrate could be released in an area where the microbe of interest would be able to have access to it. Again, is that an accurate reflection of what was being said? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Seeking excessive validation",
                    "definition": "A communication pattern where a speaker frequently asks for confirmation or approval of their statements or understanding, potentially indicating a lack of confidence or an over-reliance on external validation.",
                    "justification": "The speaker concludes their detailed summary by explicitly asking for confirmation of their understanding with the phrase, \"Again, is that an accurate reflection of what was being said?\", which, with the word 'Again,' suggests a recurring need for validation from the group."
                },
                {
                    "code_name": "Redundant communication",
                    "definition": "The act of repeating information or summarizing points that have already been adequately covered, potentially slowing down progress or indicating a lack of new contribution.",
                    "justification": "The speaker provides a detailed re-statement of an idea, \"Um, and then even targeted ways of getting that substrate to a certain area... that substrate could be released in an area where the microbe of interest would be able to have access to it.\", and then asks for confirmation with \"Again, is that an accurate reflection of what was being said?\", indicating a pattern of re-iterating and re-validating points that have been discussed across multiple turns."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: I think so. I think Tom also mentioned that if we could um identify a specific substrate that will stimulate a very specific microbe then, right? Is that what you said, Tom? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Right. Um, and it could be that you you may have to artificially create that. But yeah. I'm sure there's you know, certain things that I mean fiber, right? Fiber is good for you, probably leads to other things besides. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Vague/General Contribution",
                    "definition": "The speaker offers a contribution that is overly broad, lacks specific scientific detail, or relies on common knowledge rather than advancing the focused technical discussion. This can hinder the development of concrete research ideas.",
                    "justification": "Tom's example of 'fiber' and the statement 'Fiber is good for you, probably leads to other things besides' is a general, common-knowledge observation that does not contribute specific scientific insight or actionable ideas to the ongoing discussion about identifying and targeting specific substrates for specific microbes. This vagueness can impede the formation of a focused grant proposal. Verbatim quote: 'I mean fiber, right? Fiber is good for you, probably leads to other things besides.'"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Um, and then this was a really interesting bit, the value of measuring these levels of metabolites. Um, so even if you measure that there's a difference, say between again like a healthy versus a disease state, what is the impact of that? So you know you have a difference, but is the disease state say if it's got a reduced level of short chain fatty acids in the circulation, is that still saturation for that that person? Um, and is there a way that we can overcome that uh or would the way that we deliver said drug, if it's a short chain fatty acid for example, if we just feed that into the diet versus uh changing the microbiota so that we increase short chain fatty acid capability from the from the microbiota itself, does does that have an effect on the pharmacodynamics of the drug's ability or access to a different tissue site. Um, and then finally, this conversation about metal ions, there's a lot that sort of was happening while I was trying to get these notes um together, but it sounded like ultimately really there are indications that the microbiota has something to do with uh heavy metal metabolism. There's a lot that we don't understand and technically we don't we don't understand it because there are so many technical challenges just in terms of measurement, reporting across studies and one thing that could really advance the field here would be sensors for metal content and species uh in vivo in real time and then within that looking for whether or not these heavy metals are acting as electron acceptors or versus enzyme cofactors. How do we feel about this? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Extended monologue",
                    "definition": "The speaker takes a disproportionately long turn, covering multiple distinct points and questions, which may limit opportunities for others to contribute or respond.",
                    "justification": "The speaker delivers a very long and detailed summary of multiple complex scientific points and poses several questions without interruption, as evidenced by the extensive length of the utterance: \"Um, and then this was a really interesting bit, the value of measuring these levels of metabolites... How do we feel about this?\""
                },
                {
                    "code_name": "Posing multiple complex questions",
                    "definition": "The speaker asks several distinct and complex questions within a single turn, potentially overwhelming listeners or making it difficult to engage with any specific point.",
                    "justification": "Within a single, lengthy utterance, the speaker poses multiple complex scientific questions, such as \"what is the impact of that? ... does does that have an effect on the pharmacodynamics of the drug's ability or access to a different tissue site. ... How do we feel about this?\", which could make it challenging for others to respond effectively."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Good. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Seungh: Very well uh transcribed. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Okay. Um, I am going to stop sharing and mute myself again and just continue adding, but if you guys want to just continue discussing, I'll try and oh sorry, Sarah, I misspelled your name on that. Um, I'll just keep doing this. Uh, any of you guys want to chat, I'll try and add whatever I can as you as you go. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Withdrawal from active participation",
                    "definition": "A participant explicitly states their intention to cease active verbal contribution to the scientific discussion, often shifting to a more passive or supportive role. This can reduce their perceived engagement and intellectual contribution.",
                    "justification": "Lisa states, \"I am going to stop sharing and mute myself again and just continue adding, but if you guys want to just continue discussing\" [char_start=20, char_end=131], explicitly indicating her intent to withdraw from active verbal participation in the scientific exchange."
                },
                {
                    "code_name": "Volunteering for administrative task",
                    "definition": "A participant volunteers to take on a task that is primarily administrative or logistical (e.g., note-taking, transcribing) rather than directly engaging in the scientific discussion or problem-solving. This can inadvertently diminish their perceived role as a scientific leader or equal contributor.",
                    "justification": "Lisa explicitly states, \"I am going to stop sharing and mute myself again and just continue adding\" [char_start=20, char_end=90], volunteering to focus on note-taking/transcribing, an administrative task, rather than active scientific discussion."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: I can do that if you would like a break. But if you want to do it, go for it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of Initiative",
                    "definition": "The speaker avoids taking a clear lead or responsibility for a task, instead deferring the decision or action back to another participant.",
                    "justification": "Elizabeth offers to take over a task but immediately defers the decision back to Lisa, stating, \"But if you want to do it, go for it,\" which explicitly shows a reluctance to take strong initiative."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Uh, no, if you want to if you want to do it, absolutely happy. I mean you had a lot to to add to the discussion, so I think you're a good represent representative for us. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Happy to do it. Thanks for all the good note taking. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: That's great. Uh, Lisa, remember we only have one one slide. Yeah. Let's stick to one slide. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Imposing constraints/directives",
                    "definition": "A speaker explicitly states a limitation or gives a direct instruction that restricts the scope or method of work, potentially stifling initiative or creativity.",
                    "justification": "The speaker reminds another participant of a strict limitation and issues a directive, stating, \"Uh, Lisa, remember we only have one one slide. Yeah. Let's stick to one slide.\" This directly limits the scope of work for the other participant, potentially stifling their initiative."
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: And just um highlights salient points. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Overly Prescriptive",
                    "definition": "The speaker provides excessively detailed or rigid instructions for a task, potentially limiting the autonomy or creative input of others involved in the collaboration.",
                    "justification": "The speaker gives a direct instruction about the content of a shared task, stating \"And just um highlights salient points,\" which, in the context of preparing a summary, can be seen as overly prescriptive rather than allowing the team member to use their own judgment."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah, I thought I'd bring up in the last couple minutes. Um, I know there's um uh work that's at least gone on in the sort of synbio microbiome space of using engineered bugs as kind of metabolic sinks within the microbiome. So not necessarily caring about their natural activity whatsoever, uh but the two examples that were in PKU where there's accumulation of phenyllalanine and as well as in hyperammonemia, kind of the idea of engineering bugs to scavenge those since they are circulated through the gut. Um, and it's kind of very indirect. They are um associated with neurological diseases. Um, but they're not necessarily associated with the microbiome, but it's at least another thought of maybe we don't even need to understand really what's going on and really just use the microbiome as an agent through which we could engineer the metabolome of the host provided these molecules are, you know, going through inter circulation and that's something. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Introducing late idea",
                    "definition": "Proposing a new, potentially complex idea late in the discussion, which may divert focus or be difficult to integrate into existing plans.",
                    "justification": "The speaker explicitly states they are bringing this up 'in the last couple minutes,' suggesting it's a new thought introduced late in the meeting, potentially disrupting the flow or the agreed-upon focus. Quote: \"I thought I'd bring up in the last couple minutes.\""
                },
                {
                    "code_name": "Downplaying scientific rigor",
                    "definition": "Proposing an approach that explicitly de-emphasizes the need for deep scientific understanding, which could be perceived negatively in a research collaboration.",
                    "justification": "The speaker suggests an approach where 'maybe we don't even need to understand really what's going on,' which could indicate a lack of commitment to fundamental scientific inquiry. Quote: \"maybe we don't even need to understand really what's going on\""
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Elizabeth, I know you're busy, but is is iron three more of an indicator of disease or is the fact that there is that species around, is that what actually serves as a catalyst for um you know, is it is it causal or correlative that the iron three is around during certain disease states? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Apologetic Preamble",
                    "definition": "The speaker prefaces a question or request with an acknowledgment of the recipient's busy schedule or an apology, which can inadvertently create a sense of imposition or subtly devalue the interaction.",
                    "justification": "Tom Mansell begins his question with 'Elizabeth, I know you're busy, but', which can be interpreted as an apologetic preamble that might make the recipient feel their time is being imposed upon or that the inquiry is of lesser importance, potentially hindering direct communication."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Um, I would say there's an element of both. Uh, I think that we think that there's a increase as a field we think there's, you know, an increase in iron three is a consequence of uh inflammation of Ross, but I think that we're also seeing in a few interesting contexts of um there was a paper in E life 2018 ish. Um, that uh from Warren Stevens group uh where they uh gave mice antibiotics and they see differences in redox potential. Um, and it would be uh interesting to see like how does that actually change ironciation as a consequence of of antibiotics as well and what sort of readouts does this end up um or impacts does this end up having on the the activity of them bacteria just because now as I think you had mentioned or um I mean was Jay like uh umphores, like now maybe that we have iron three bacteria producing morephores. Um, which could also induce I think more pathogenicity as well. Um, when there's more iron three around, which has been seen in other contexts. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Lack of conciseness",
                    "definition": "The speaker provides an overly long or detailed response that could be condensed without losing essential meaning, potentially hindering efficient discussion.",
                    "justification": "The utterance is a lengthy response to a direct question, including specific research details and speculative connections, which makes it less direct and efficient than it could be, as seen in the extended explanation starting with, 'Um, I would say there's an element of both. Uh, I think that we think that there's a increase as a field we think there's, you know, an increase in iron three is a consequence of uh inflammation of Ross, but I think that we're also seeing in a few interesting contexts of um there was a paper in E life 2018 ish. Um, that uh from Warren Stevens group...'"
                },
                {
                    "code_name": "Rambling",
                    "definition": "The speaker's communication lacks a clear, focused structure, often characterized by hesitations, digressions, or a meandering flow of ideas.",
                    "justification": "The utterance exhibits a meandering flow, moving from a general scientific understanding to a specific research paper, and then to speculative connections about siderophores and pathogenicity, punctuated by filler words like 'Um' and 'Uh', as in 'Um, I would say there's an element of both. Uh, I think that we think that there's a increase as a field we think there's, you know, an increase in iron three is a consequence of uh inflammation of Ross, but I think that we're also seeing in a few interesting contexts of um there was a paper in E life 2018 ish...'"
                }
            ]
        }
    },
    {
        "utterance": "Tom Mansell: Some antibiotics arephores. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Yep. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Right shuttles. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Right, shuttles. You have shuttles also. You have molecules that are shuttles. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Repetitive/Redundant Contribution",
                    "definition": "The speaker reiterates a point or idea that has already been clearly stated or is evident from the ongoing discussion, without adding new information or advancing the conversation.",
                    "justification": "The speaker repeats the concept of 'shuttles' multiple times within this single utterance, stating 'Right, shuttles. You have shuttles also. You have molecules that are shuttles.' This reiterates a point already established in the preceding turns by other speakers and the speaker's own previous utterance, thus not advancing the discussion."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: the concern there is like it's fine for the person, but after they excrete it then where does it go? And that's where the EPA gets in and that's where the concerns uh really are. And also for the ethical dilemma of like, well, you could spread a microbiome from one person to another if you're in the same household. And even if person A is sick and is perfectly fine with eating an engineered bug, but you know, their brother or sister or spouse or kid is not and it transfers to them, then they've been unknowingly dosed with a drug. So there's definitely some ethical um issue there. But regardless, it seems like, you know, they're trying to grapple with the the ethics both on the environmental and the medical side of that and it's all moving forward uh at least from my opinion. It's not something it's something that should be figured out and not something that should be necessarily a bar to the field in general. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Downplaying Risks/Concerns",
                    "definition": "The speaker acknowledges potential problems or negative implications but then minimizes their significance or impact, suggesting they are not substantial obstacles.",
                    "justification": "The speaker raises significant ethical and environmental concerns regarding engineered bugs but then downplays their potential to hinder progress by stating, 'But regardless, it seems like, you know, they're trying to grapple with the the ethics both on the environmental and the medical side of that and it's all moving forward uh at least from my opinion. It's not something it's something that should be figured out and not something that should be necessarily a bar to the field in general.' This suggests the issues are not a major impediment."
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Thank you. Mark on that line like, I mean, this is this is probably related to your your line of work, but is there uh companies that are engineering, you know, bugs and and actually doing clinical trials like for particular diseases? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah. Yeah, so the furthest yeah, there's a couple of them. Um so there's definitely folks in the cancer space that have been doing it for a really long time. Uh there's one company that was uh I I mean active biotics. I think it's been acquired by a bunch of different people so I don't even know what it's called anymore. And there's another one based in Boston uh called Synlogic. Um these are all in like phase two trials, all orally dosed. I know some folks that worked at Synlogic and their clinical trial was giving people a half a liter of bacterial culture at a concentration of like 10 to the 11 CFU per mill. And that was approved by the FDA. So it's like really high dosing of bugs going into people um and they've had good phase two results I think or phase 1A phase 1B sorry, phase two results and they're moving forward from there. So ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Imprecise Information Sharing",
                    "definition": "The speaker provides information but expresses uncertainty about its accuracy or completeness, or corrects themselves mid-sentence, which can signal a lack of definitive knowledge.",
                    "justification": "The speaker mentions a company but states, \"I think it's been acquired by a bunch of different people so I don't even know what it's called anymore,\" indicating a lack of current, precise knowledge. Further, they correct themselves regarding trial phases, saying, \"they've had good phase two results I think or phase 1A phase 1B sorry, phase two results,\" demonstrating uncertainty in the details provided."
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: Got it. It's it's happening is the short answer. Got it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: What disease though? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Uh so that was the I think that was the PKU example. Um I think they also had a phase one ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expresses uncertainty",
                    "definition": "The speaker uses hedging language or phrases that indicate a lack of definitive knowledge or confidence in the information being presented.",
                    "justification": "The speaker repeatedly uses 'I think' when providing information, suggesting uncertainty or a lack of definitive knowledge, as seen in 'I think that was the PKU example. Um I think they also had a phase one'."
                },
                {
                    "code_name": "Provides incomplete information",
                    "definition": "The speaker offers information that is not fully elaborated or is cut short, leaving details unaddressed or the statement unfinished.",
                    "justification": "The speaker's statement ends abruptly and incompletely with 'phase one .', leaving the information unfinished and potentially requiring further elaboration."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: uh thing for hyperammonemia that uh wasn't as positive so they're going forward with PKU. And now them as well as almost everyone else is going after cancer immunotherapy as well. trying to use those as to modulate the the the utility of those drugs. So I think those I mean those pertain to this, but you know, a lot of people are thinking about that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Downplaying novelty",
                    "definition": "The speaker minimizes the uniqueness or innovation of an idea, potentially making it seem less valuable or competitive for a grant proposal.",
                    "justification": "The speaker explicitly states that 'almost everyone else is going after cancer immunotherapy as well' and 'a lot of people are thinking about that,' which diminishes the perceived originality and distinctiveness of the discussed scientific approach."
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: How do you get those bugs out? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: After after the job's done. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah, oh so most of them are engineered with auxotrophies so that they're like only uh by the time they're excreted, they're already dead is the way that these things are. So none of these applications are of like trying to colonize a host for months on end and for them to dynamically respond. They're mostly just using the bugs as like bags to carry enzymes or some relatively complex system so that I can carry out an activity and then sort of self-destruct by the time they leave. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: I see. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: But they could always evolve uh ways around these kill switches. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Pessimistic framing",
                    "definition": "Presenting a potential challenge or limitation with an emphasis on its negative or persistent nature, without offering immediate solutions or a balanced perspective, which can discourage collaborative problem-solving.",
                    "justification": "The speaker highlights a persistent potential problem ('But they could always evolve uh ways around these kill switches.') without offering a solution or a more balanced outlook, which can be perceived as pessimistic and hinder collaborative progress."
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: That's where a good deal of the concern is. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Emphasizing Risks",
                    "definition": "The speaker explicitly highlights or reiterates potential problems, dangers, or negative aspects of an idea or situation, potentially without offering solutions.",
                    "justification": "The utterance explicitly states, \"That's where a good deal of the concern is,\" drawing attention to and emphasizing existing risks or problems related to the topic without immediately pivoting to solutions."
                }
            ]
        }
    },
    {
        "utterance": "Will Ludington: Yeah, do people look at the I mean the temperature is a major factor in terms of uh how well something can deal with an auxotrophy. Um so and often times like lower temperature makes things more tolerant. Um is that like in in that field? Is that a uh I mean there I assume they're engineer at 37 degrees but then they get on the environment and they're at, you know, significantly less than 37 degrees. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: Yeah, and I know like even um there's like some stuff out of Pen Silver's group which was using that temperature differential as an indicator that a bacteria is escaping the body and therefore should self-destruct. So could kind of detect that it wasn't room temperature, it's ingested, goes up to 37 at that point it turns on its therapeutic capabilities and then when it goes back out the other end and it drops back down to room temperature so that's when it's going to initiate the whole self-destruct mechanism. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: At least some people are thinking about that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Mark Mimee: We don't work on that. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Shutting down idea/topic",
                    "definition": "The speaker explicitly dismisses or closes off a topic or idea, preventing further discussion or exploration of its relevance to potential collaboration.",
                    "justification": "The speaker explicitly states that their group does not work on the previously discussed topic, which can be perceived as shutting down further exploration of that idea as a potential area of collaboration. \"We don't work on that.\""
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: We have uh about a minute left. Lisa, how are you doing with that? Uh it is messaged Elizabeth. It's uh done and she's taken a look at it now to see make sure she knows what she wants to say, I think. Yes. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Imposing Time Constraints",
                    "definition": "The speaker explicitly states a limited amount of time remaining, which can rush the discussion, prevent thorough exploration of ideas, or create pressure on participants to conclude quickly.",
                    "justification": "The speaker explicitly states, \"We have uh about a minute left,\" which directly imposes a time limit on the ongoing discussion, potentially cutting short further collaborative ideation."
                },
                {
                    "code_name": "Ambiguous Communication",
                    "definition": "The speaker's statement contains elements of uncertainty, hesitation, or lack of clear information, which can lead to confusion, misinterpretation, or a perception of disorganization.",
                    "justification": "The speaker concludes a status update with \"I think. Yes.\", introducing a slight ambiguity or uncertainty about Elizabeth's readiness or understanding, which could hinder smooth transitions or clear expectations."
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: Yeah, Lisa did a really nice job organizing all of those like everyone's thoughts. It looks really nice. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: This was a really like I'm sorry that I didn't have much to add uh listening to you guys, but so much fun to think about and this this particular conversation seemed like the one that really uncovered like we don't know what we're doing. Like there is so much. Like it seemed like every other conversation that was in there was like, you know, like everybody's got their own bits of expertise and areas that they're looking at, but this is just black boxish is fun. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Understated Contribution",
                    "definition": "The speaker apologizes for or downplays their own contribution, potentially signaling a lack of confidence or active engagement.",
                    "justification": "Lisa explicitly states, \"I'm sorry that I didn't have much to add uh listening to you guys,\" indicating a perceived lack of contribution."
                },
                {
                    "code_name": "Expressing Group Uncertainty",
                    "definition": "The speaker articulates a perception that the group lacks clear understanding or direction on a particular topic, potentially undermining collective confidence.",
                    "justification": "Lisa observes that the conversation \"uncovered like we don't know what we're doing,\" highlighting a collective lack of clarity."
                },
                {
                    "code_name": "Highlighting Domain Ambiguity",
                    "definition": "The speaker identifies a specific problem domain as unclear or undefined ('black boxish'), contrasting it with other areas where expertise is evident.",
                    "justification": "Lisa describes the topic as \"black boxish,\" implying a lack of clear understanding compared to other discussions where \"everybody's got their own bits of expertise.\""
                }
            ]
        }
    },
    {
        "utterance": "Jae Sung: I I really like this type of, you know, conference. It's like everybody just gets together from various domains and just talk and just, you know, a nice theme comes out just organically. You know, rather than the conferences we're used to, we just listen and just listen to talks, you know, talk by talk by talk and hopefully get to ask questions, but this was really fun and very good creative exercise. Um, thanks for all the facilitators, Emily and Rosa for uh, you know, helping us with organize everything. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Uh we're going to close in 30 seconds. I don't see the update yet on the slides. Um so I don't know if Lisa or Elizabeth is going to put it up. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Unclear Task Ownership",
                    "definition": "The speaker explicitly states uncertainty about who is responsible for a specific task, indicating a lack of clear assignment or understanding of roles within the group.",
                    "justification": "The speaker expresses a lack of clarity regarding who is responsible for presenting the updated slides, stating, 'I don't know if Lisa or Elizabeth is going to put it up.' This highlights a potential breakdown in task assignment or communication."
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Um I think I see it. Uh maybe I'm looking at the wrong spot though. I see 3.1 key points. Is that the right spot? ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Lisa Osborne: I hope so. That's where I put it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "Expressed Uncertainty",
                    "definition": "The speaker communicates a lack of definitive knowledge or confidence regarding a piece of information or action, rather than providing a clear confirmation or denial.",
                    "justification": "The speaker uses 'I hope so' to convey uncertainty about the correct location of the slides, rather than a firm confirmation, which could lead to minor ambiguity in a collaborative task. Quote: 'I hope so.'"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Okay, I see it. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: I see it too. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Rosa Krajmalnik-Brown: Okay. Thanks everyone. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    },
    {
        "utterance": "Elizabeth Bess: Thanks. ",
        "annotations": {
            "codes": [
                {
                    "code_name": "none"
                }
            ]
        }
    }
]